Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

BACKGROUND: Significant controversy remains regarding the care of patients with clinical stage III (N2‐positive) NSCLC. Although multimodality therapy is effective, the roles of surgery, chemotherapy, and radiotherapy are not fully defined and the optimal treatment approach is not firmly established...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Behera, Madhusmita, Steuer, Conor E., Liu, Yuan, Fernandez, Felix, Fu, Chao, Higgins, Kristin A., Gillespie, Theresa W., Pakkala, Suchita, Pillai, Rathi N., Force, Seth, Belani, Chandra P., Khuri, Fadlo R., Curran, Walter J., Ramalingam, Suresh S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2020
Pynciau:
Lung Cancer
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288644/
https://ncbi.nlm.nih.gov/pubmed/31943520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0661
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg